Su-Yi Tseng

607 total citations
13 papers, 465 citations indexed

About

Su-Yi Tseng is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Su-Yi Tseng has authored 13 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 7 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Su-Yi Tseng's work include Immunotherapy and Immune Responses (11 papers), T-cell and B-cell Immunology (6 papers) and Immune Cell Function and Interaction (6 papers). Su-Yi Tseng is often cited by papers focused on Immunotherapy and Immune Responses (11 papers), T-cell and B-cell Immunology (6 papers) and Immune Cell Function and Interaction (6 papers). Su-Yi Tseng collaborates with scholars based in United States, Germany and United Kingdom. Su-Yi Tseng's co-authors include Michael L. Dustin, Mengling Liu, Gabriele Campi, Rajat Varma, Janelle Waite, Santosha A. Vardhana, Kevin Nishimoto, Jane Lebkowski, Anita Reddy and Paul J. Fairchild and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Su-Yi Tseng

13 papers receiving 454 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Su-Yi Tseng United States	9	314	154	98	79	62	13	465
Laura I. Salazar‐Fontana United States	8	312 1.0×	149 1.0×	93 0.9×	80 1.0×	85 1.4×	10	499
Elaine P. Dopfer Germany	13	374 1.2×	157 1.0×	172 1.8×	81 1.0×	34 0.5×	15	566
Julia M. Laufer Switzerland	9	203 0.6×	116 0.8×	146 1.5×	37 0.5×	34 0.5×	9	349
Mezida B. Saeed Sweden	8	281 0.9×	81 0.5×	113 1.2×	32 0.4×	36 0.6×	10	388
Marcelo D. Guthmann Argentina	11	331 1.1×	265 1.7×	93 0.9×	111 1.4×	32 0.5×	15	483
G. Bonello United States	9	376 1.2×	226 1.5×	211 2.2×	39 0.5×	47 0.8×	13	600
Lynn Kamen United States	11	259 0.8×	156 1.0×	72 0.7×	80 1.0×	44 0.7×	22	451
Anupama Pasam Australia	10	305 1.0×	235 1.5×	245 2.5×	45 0.6×	34 0.5×	18	591
Stephen P. Persaud United States	8	366 1.2×	90 0.6×	119 1.2×	29 0.4×	23 0.4×	16	472
Dmitrij Hristodorov Germany	13	225 0.7×	238 1.5×	100 1.0×	196 2.5×	18 0.3×	21	451

Countries citing papers authored by Su-Yi Tseng

Since Specialization

Citations

This map shows the geographic impact of Su-Yi Tseng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su-Yi Tseng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su-Yi Tseng more than expected).

Fields of papers citing papers by Su-Yi Tseng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Su-Yi Tseng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su-Yi Tseng. The network helps show where Su-Yi Tseng may publish in the future.

Co-authorship network of co-authors of Su-Yi Tseng

This figure shows the co-authorship network connecting the top 25 collaborators of Su-Yi Tseng. A scholar is included among the top collaborators of Su-Yi Tseng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Su-Yi Tseng. Su-Yi Tseng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Roider, Helge G., Sabine Hoff, Su-Yi Tseng, et al.. (2024). Selective depletion of tumor-infiltrating regulatory T cells with BAY 3375968, a novel Fc-optimized anti-CCR8 antibody. Clinical and Experimental Medicine. 24(1). 122–122. 10 indexed citations

Rajasekaran, Narendiran, Xiaoguang Wang, Sruthi Ravindranathan, et al.. (2024). Toripalimab, a therapeutic monoclonal anti-PD-1 antibody with high binding affinity to PD-1 and enhanced potency to activate human T cells. Cancer Immunology Immunotherapy. 73(3). 60–60. 17 indexed citations

Ravindranathan, Sruthi, Xiaoguang Wang, Daniel J. Chin, et al.. (2023). 468 Characteristics of toripalimab: a next generation anti-PD-1 antibody with potent T cell activation and enhanced clinical efficacy irrespective of PD-L-1 status. SHILAP Revista de lepidopterología. A522–A526. 1 indexed citations

Roider, Helge G., Su-Yi Tseng, Sabine Hoff, et al.. (2022). Abstract 2866: BAY 3375968: An afucosylated anti-CCR8 antibody depleting activated intratumoral regulatory T cells as a cancer immunotherapy. Cancer Research. 82(12_Supplement). 2866–2866. 1 indexed citations

Morgan, Hannah L., Su-Yi Tseng, Natacha Szely, et al.. (2019). Evaluation of in vitro Assays to Assess the Modulation of Dendritic Cells Functions by Therapeutic Antibodies and Aggregates. Frontiers in Immunology. 10. 601–601. 39 indexed citations

Tseng, Su-Yi, et al.. (2011). Differentiation of Dendritic Cells from Human Embryonic Stem Cells. Methods in molecular biology. 767. 449–461. 7 indexed citations

Nishimoto, Kevin, Su-Yi Tseng, Jane Lebkowski, & Anita Reddy. (2011). Modification of Human Embryonic Stem Cell-Derived Dendritic Cells with mRNA for Efficient Antigen Presentation and Enhanced Potency. Regenerative Medicine. 6(3). 303–318. 6 indexed citations

Tseng, Su-Yi, Kevin Nishimoto, Anish Sen Majumdar, et al.. (2009). Generation of Immunogenic Dendritic Cells from Human Embryonic Stem Cells without Serum and Feeder Cells. Regenerative Medicine. 4(4). 513–526. 47 indexed citations

Milstein, Oren, Su-Yi Tseng, Toby Starr, et al.. (2008). Nanoscale Increases in CD2-CD48-mediated Intermembrane Spacing Decrease Adhesion and Reorganize the Immunological Synapse. Journal of Biological Chemistry. 283(49). 34414–34422. 55 indexed citations

10.

Tseng, Su-Yi, Janelle Waite, Mengling Liu, Santosha A. Vardhana, & Michael L. Dustin. (2008). T Cell-Dendritic Cell Immunological Synapses Contain TCR-dependent CD28-CD80 Clusters That Recruit Protein Kinase Cθ. The Journal of Immunology. 181(7). 4852–4863. 83 indexed citations

11.

Dustin, Michael L., Su-Yi Tseng, Rajat Varma, & Gabriele Campi. (2006). T cell–dendritic cell immunological synapses. Current Opinion in Immunology. 18(4). 512–516. 81 indexed citations

12.

Tseng, Su-Yi, Mengling Liu, & Michael L. Dustin. (2005). CD80 Cytoplasmic Domain Controls Localization of CD28, CTLA-4, and Protein Kinase Cθ in the Immunological Synapse. The Journal of Immunology. 175(12). 7829–7836. 56 indexed citations

13.

Tseng, Su-Yi & Michael L. Dustin. (2002). T-cell activation: a multidimensional signaling network. Current Opinion in Cell Biology. 14(5). 575–580. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact